Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8981 |
High Similarity |
NPD5761 |
Phase 2 |
0.8981 |
High Similarity |
NPD5760 |
Phase 2 |
0.8382 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD6764 |
Approved |
0.8092 |
Intermediate Similarity |
NPD6765 |
Approved |
0.791 |
Intermediate Similarity |
NPD6785 |
Approved |
0.791 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7396 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7362 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7326 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7326 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7322 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7209 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.72 |
Intermediate Similarity |
NPD3749 |
Approved |
0.72 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD920 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7126 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6799 |
Approved |
0.6983 |
Remote Similarity |
NPD1247 |
Approved |
0.6966 |
Remote Similarity |
NPD919 |
Approved |
0.6964 |
Remote Similarity |
NPD2800 |
Approved |
0.6961 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD3882 |
Suspended |
0.6946 |
Remote Similarity |
NPD2344 |
Approved |
0.6946 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6941 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6927 |
Remote Similarity |
NPD5494 |
Approved |
0.6923 |
Remote Similarity |
NPD3750 |
Approved |
0.6905 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD5402 |
Approved |
0.6893 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6889 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6886 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD6100 |
Approved |
0.6886 |
Remote Similarity |
NPD2796 |
Approved |
0.6886 |
Remote Similarity |
NPD6099 |
Approved |
0.6871 |
Remote Similarity |
NPD3268 |
Approved |
0.6854 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6851 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6848 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6845 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6825 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6805 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD7458 |
Discontinued |
0.68 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6793 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6793 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6786 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6784 |
Remote Similarity |
NPD2309 |
Approved |
0.6782 |
Remote Similarity |
NPD5403 |
Approved |
0.678 |
Remote Similarity |
NPD1934 |
Approved |
0.6768 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6765 |
Remote Similarity |
NPD1243 |
Approved |
0.6763 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.676 |
Remote Similarity |
NPD7057 |
Phase 3 |
0.676 |
Remote Similarity |
NPD7058 |
Phase 2 |
0.676 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6758 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6757 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6755 |
Remote Similarity |
NPD8312 |
Approved |
0.6755 |
Remote Similarity |
NPD8313 |
Approved |
0.6746 |
Remote Similarity |
NPD5762 |
Approved |
0.6746 |
Remote Similarity |
NPD5763 |
Approved |
0.6726 |
Remote Similarity |
NPD3748 |
Approved |
0.6726 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6722 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6721 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6721 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6685 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6685 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6685 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6683 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6667 |
Remote Similarity |
NPD3764 |
Approved |
0.6667 |
Remote Similarity |
NPD4966 |
Approved |
0.6667 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD5401 |
Approved |
0.6667 |
Remote Similarity |
NPD4965 |
Approved |
0.6667 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6649 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6648 |
Remote Similarity |
NPD2801 |
Approved |
0.6647 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6646 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6632 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.6629 |
Remote Similarity |
NPD1512 |
Approved |
0.6628 |
Remote Similarity |
NPD7003 |
Approved |
0.6628 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6627 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6626 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6614 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6612 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6607 |
Remote Similarity |
NPD1607 |
Approved |
0.66 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6596 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6596 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6593 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6592 |
Remote Similarity |
NPD37 |
Approved |
0.6587 |
Remote Similarity |
NPD4140 |
Approved |
0.6587 |
Remote Similarity |
NPD1240 |
Approved |
0.6584 |
Remote Similarity |
NPD1608 |
Approved |
0.658 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6578 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6576 |
Remote Similarity |
NPD5711 |
Approved |
0.6576 |
Remote Similarity |
NPD5710 |
Approved |
0.6573 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6564 |
Remote Similarity |
NPD3266 |
Approved |
0.6564 |
Remote Similarity |
NPD2797 |
Approved |
0.6564 |
Remote Similarity |
NPD3267 |
Approved |
0.6561 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6561 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6543 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6533 |
Remote Similarity |
NPD6779 |
Approved |
0.6533 |
Remote Similarity |
NPD6781 |
Approved |
0.6533 |
Remote Similarity |
NPD6780 |
Approved |
0.6533 |
Remote Similarity |
NPD6778 |
Approved |
0.6533 |
Remote Similarity |
NPD6782 |
Approved |
0.6533 |
Remote Similarity |
NPD6776 |
Approved |
0.6533 |
Remote Similarity |
NPD6777 |
Approved |
0.6527 |
Remote Similarity |
NPD6663 |
Approved |
0.6526 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6517 |
Remote Similarity |
NPD7697 |
Approved |
0.6517 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6517 |
Remote Similarity |
NPD7698 |
Approved |
0.6514 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD1511 |
Approved |
0.6509 |
Remote Similarity |
NPD6651 |
Approved |
0.6508 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6505 |
Remote Similarity |
NPD2403 |
Approved |
0.6493 |
Remote Similarity |
NPD7907 |
Approved |
0.6489 |
Remote Similarity |
NPD7054 |
Approved |
0.6488 |
Remote Similarity |
NPD7874 |
Approved |
0.6488 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6486 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6485 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6485 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6482 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6481 |
Remote Similarity |
NPD9717 |
Approved |
0.6476 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6476 |
Remote Similarity |
NPD4665 |
Approved |
0.6467 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6463 |
Remote Similarity |
NPD1203 |
Approved |
0.6455 |
Remote Similarity |
NPD7472 |
Approved |
0.645 |
Remote Similarity |
NPD4107 |
Approved |
0.645 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.645 |
Remote Similarity |
NPD447 |
Suspended |
0.6444 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.644 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6437 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6436 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6436 |
Remote Similarity |
NPD7228 |
Approved |
0.6432 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD7961 |
Discontinued |
0.6424 |
Remote Similarity |
NPD2798 |
Approved |
0.6424 |
Remote Similarity |
NPD5647 |
Approved |
0.6412 |
Remote Similarity |
NPD6353 |
Approved |
0.641 |
Remote Similarity |
NPD8360 |
Approved |
0.641 |
Remote Similarity |
NPD4287 |
Approved |
0.641 |
Remote Similarity |
NPD8361 |
Approved |
0.6407 |
Remote Similarity |
NPD7095 |
Approved |
0.6404 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6404 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6404 |
Remote Similarity |
NPD8319 |
Approved |
0.6402 |
Remote Similarity |
NPD1876 |
Approved |
0.64 |
Remote Similarity |
NPD3887 |
Approved |
0.6398 |
Remote Similarity |
NPD7315 |
Approved |
0.6398
|
Remote Similarity |
NPD17 |
Approved |